Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Merrimack Pharmaceuticals stock
Learn how to easily invest in Merrimack Pharmaceuticals stock.
Merrimack Pharmaceuticals Inc is a biotechnology business based in the US. Merrimack Pharmaceuticals shares (MACK) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in Merrimack Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MACK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- MACK shares summary
- Compare share dealing platforms
- Is MACK stock a buy or sell?
- Stock performance over time
- Are MACK shares over-valued?
- Merrimack Pharmaceuticals's financials
- How volatile are MACK shares?
- Does Merrimack Pharmaceuticals pay a dividend?
- Have MACK shares ever split?
- Other common questions
Merrimack Pharmaceuticals stock price (NASDAQ: MACK)Use our graph to track the performance of MACK stocks over time.
Merrimack Pharmaceuticals shares at a glance
|Latest market close||$4.55|
|52-week range||$3.66 - $9.45|
|50-day moving average||$4.14|
|200-day moving average||$5.31|
|Wall St. target price||$4.00|
|Dividend yield||$1.497 (34.18%)|
|Earnings per share (TTM)||$-0.23|
Buy Merrimack Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Merrimack Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Merrimack Pharmaceuticals price performance over time
|1 week (2022-01-12)||5.57%|
|1 month (2021-12-16)||14.04%|
|3 months (2021-10-19)||0.44%|
|6 months (2021-07-19)||-27.08%|
|1 year (2021-01-19)||-40.52%|
|2 years (2020-01-17)||40.00%|
|3 years (2019-01-18)||5|
|5 years (2017-01-18)||52.17%|
Is Merrimack Pharmaceuticals stock undervalued or overvalued?
Valuing Merrimack Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merrimack Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Merrimack Pharmaceuticals's PEG ratio
Merrimack Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merrimack Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Merrimack Pharmaceuticals's EBITDA
Merrimack Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $134,000.
The EBITDA is a measure of a Merrimack Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
Merrimack Pharmaceuticals financials
|Gross profit TTM||$-9,100,000|
|Return on assets TTM||-11.05%|
|Return on equity TTM||-19.7%|
|Market capitalisation||$62.2 million|
TTM: trailing 12 months
Merrimack Pharmaceuticals share dividends
We're not expecting Merrimack Pharmaceuticals to pay a dividend over the next 12 months.
Have Merrimack Pharmaceuticals's shares ever split?
Merrimack Pharmaceuticals's shares were split on a 1271:1000 basis on 5 September 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1271 shares. This wouldn't directly have changed the overall worth of your Merrimack Pharmaceuticals shares – just the quantity. However, indirectly, the new 21.3% lower share price could have impacted the market appetite for Merrimack Pharmaceuticals shares which in turn could have impacted Merrimack Pharmaceuticals's share price.
Merrimack Pharmaceuticals share price volatility
Over the last 12 months, Merrimack Pharmaceuticals's shares have ranged in value from as little as $3.66 up to $9.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Merrimack Pharmaceuticals's is 2.0649. This would suggest that Merrimack Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Merrimack Pharmaceuticals overview
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts. .
Merrimack Pharmaceuticals in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Thursday 1/13 Insider Buying Report: MACK, ASO
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of Merrimack Pharmaceuticals is owned by insiders or institutions?
Currently 0.344% of Merrimack Pharmaceuticals shares are held by insiders and 62.542% by institutions. When does the fiscal year end for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals's fiscal year ends in December. Where is Merrimack Pharmaceuticals based?
Merrimack Pharmaceuticals's address is: One Broadway, Cambridge, MA, United States, 02142 What is Merrimack Pharmaceuticals's ISIN number?
Merrimack Pharmaceuticals's international securities identification number is: US5903282094 What is Merrimack Pharmaceuticals's CUSIP number?
Merrimack Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 590328100
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert